Common Contracts
3 similar Clinical Trial Agreement contracts
ContractClinical Trial Agreement • October 26th, 2021
CLINICAL TRIAL AGREEMENT SMLOUVA O KLINICKÉ STUDII For Protocol CC-10004-PPSO-004 pro protokol CC-10004-PPSO-004 This clinical trial agreement (hereinafter, the “Agreement”) is by and between: Tato smlouva o klinické studii (dále „smlouva”), byla uzavřena mezi těmito stranami: Amgen s.r.o having its principal office at Klimentská 1216/46, 110 02 Praha 1, Czech Republic. Company is registered under VAT number 27117804, tax exempt number CZ27117804 in the Commercial Register of the Municipal Court in Prague, Section C, Insert No. 97583; represented by xxx and xxx, duly empowered for the purposes hereof.(hereinafter the “Sponsor”) Amgen s.r.o. se sídlem Klimentská 1216/46, 110 02 Praha 1, Česká republika. Společnost je registrována s číslem IČO: 27117804, DIČ: CZ27117804 vobchodním rejstříku Městského soudu v Praze, oddíl C, vložka č. 97583; zastoupená xxx a xxx, řádně zmocněná pro účely tohoto dokumentu.(dále jen „zadavatel“) AND A Fakultní nemocnice Královské Vinohrady located at Šrobár
ContractClinical Trial Agreement • September 4th, 2020
CLINICAL TRIAL AGREEMENT SMLOUVA O KLINICKÉ STUDII For Protocol FEDR-MF-002 pro protokol FEDR-MF-002 This clinical trial agreement (hereinafter, the “Agreement”) is by and between: Tuto smlouvu o klinické studii (dále „smlouva”) uzavřely tyto strany: Impact Biomedicines, Inc. a wholly owned Subsidiary of Celgene Corporation, having its principal office at 86 Morris Avenue, Summit, NJ 07901, USA (hereinafter called „Sponsor“) represented for the purposes of this Agreement by Celgene International II Sàrl, a limited liability company organized under the laws of Switzerland having its principal office at Rue du Pré-Jorat 14, 2108 Couvet, Switzerland and represented for the purposes of the signature of this Agreement by ICON Clinical Research Limited, South County Businesspark, Leopardstown, Dublin 18, Ireland, Tax ID No. IE 8201978R (hereinafter „the CRO“) Impact Biomedicines, Inc., dceřinná společnost Celgene Corporation s hlavním sídlem v 86 Morris Avenue, Summit, NJ 07901, USA (dále je
CLINICAL TRIAL AGREEMENT SMLOUVA O KLINICKÉ STUDIIClinical Trial Agreement • March 14th, 2019
This clinical trial agreement (hereinafter, the “Agreement”) is by and between: Tato smlouva o klinické studii (dále „smlouva”), byla uzavřena mezi těmito stranami:
